TrademarkDir
(KV) KALIVIR IMMUNOTHERAPEUTICS
LIVE

Serial Number

97150678

Owner

KALIVIR IMMUNOTHERAPEUTICS, INC.

Attorney

Draeke H. Weseman

First Use Date

Dec 7, 2020

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

(KV) KALIVIR IMMUNOTHERAPEUTICS Trademark

Serial Number: 97150678 • Registration: 7392303

(KV) KALIVIR IMMUNOTHERAPEUTICS is a trademark filed by KALIVIR IMMUNOTHERAPEUTICS, INC. on December 1, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KALIVIR IMMUNOTHERAPEUTICS, INC. (9 trademarks)

240 Alpha Drive
Pittsburgh, PA 15238

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

May 21, 2024

First Use Anywhere

December 7, 2020

First Use in Commerce

December 7, 2020

Published for Opposition

May 2, 2023

Goods & Services

Medical and scientific research in the fields of immunotherapy, immunotherapeutics, biotechnology, and biopharmaceuticals; immunotherapeutic and biopharmaceutical drug development services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 21, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 21, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 19, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 18, 2024 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2024 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 11, 2024 SUPC
SOU EXTENSION 1 GRANTED
Jan 11, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 10, 2024 AITU
USE AMENDMENT FILED
Dec 19, 2023 IUAF
SOU EXTENSION 1 FILED
Dec 19, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 EEXT
TEAS STATEMENT OF USE RECEIVED
Dec 19, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 27, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 7, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP

Related Trademarks

More from this Owner

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

V.E.T. PLATFORM

V.E.T. PLATFORM

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS

V.E.T. PLATFORM

V.E.T. PLATFORM